Frontiers in cancer disparities and control
Come learn about how health communication can reduce the burden of cancer across the cancer control continuum. Dr Tan’s research interests lies in understanding the impact of mass-mediated and interpersonal communication on cancer prevention and control outcomes. To date, his research examined patient-provider communication and active information seeking among cancer survivors; direct-to-consumer advertising of cancer treatments; emerging health information technology; and advertising of novel tobacco products. His research has identified associations between these forms of health communication and important population health outcomes including surveillance adherence, preventive behaviors, and patient-reported measures of quality of life. These findings help guide future innovations in health communication interventions for cancer prevention and control. His work has resulted in over a dozen first-authored peer-reviewed papers published in leading oncology, public health and health communication journals, including Cancer, Cancer Epidemiology Biomarkers & Prevention, The Oncologist, AJPM, BMJ Tobacco Control, and Health Communication. In addition to research, Dr. Tan has over 5 years of field experience in designing, implementing and evaluating strategic communications programs in Singapore and the U.S.
Dr. Tan holds a bachelor of medicine and a bachelor of surgery (MBBS) from the National University of Singapore. In 2007 he earned dual Masters’ degrees in public health and business administration from the Johns Hopkins University School of Public Health and Carey Business School. He received his PhD in health communication from the University of Pennsylvania, Annenberg School for Communication in 2013 and completed his postdoctoral research fellowship at the NCI-funded Center of Excellence for Cancer Communication at the Annenberg School. Dr. Tan also has over 5 years of field experience in designing, implementing and evaluating strategic communications programs.